Follow Us
© 2026 Arizent. All rights reserved.
Nick Otto is a former senior editor of Employee Benefit News and Employee Benefit Adviser.
For reprint and licensing requests for this article, click here.
As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.
While the legislation's future is still unclear, there are many important things for leaders to know.
As GLP-1 spending climbs, employers are asking whether the drugs deliver enough value. Better data could help them measure the payoff more accurately.
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
Employers are under pressure to keep benefits competitive while controlling costs, driving new scrutiny of PBMs, hospital prices and GLP-1 coverage for 2027.
